Samuel Denmeade
From Wikipedia, the free encyclopedia
| This article may not meet the general notability guideline or one of the following specific guidelines for inclusion on Wikipedia: Biographies, Books, Companies, Fiction, Music, Neologisms, Numbers, Web content, or several proposals for new guidelines. If you are familiar with the subject matter, please expand or rewrite the article to establish its notability. The best way to address this concern is to reference published, third-party sources about the subject. If notability cannot be established, the article is more likely to be considered for redirection, merge or ultimately deletion, per Wikipedia:Guide to deletion. This article has been tagged since April 2008. |
Dr. Samuel Ray Denmeade is an oncologist at the Johns Hopkins University School of Medicine.
In addition to being an oncologist, he maintains an active research interest in novel ways to treat prostate cancer[citation needed]. He has been a key researcher in a number of cancer treatments, including engineering the bacterial toxin Aerolysin to target cancer cells[citation needed]. Other research includes the study of proteases, with the theory that a lethal drug could be disguised as a prodrug and only released when exposed to the enzymatic activity of PSA, PSA being present in its enzymatically active form only in the tumor and not elsewhere in the body[citation needed].
